Organon & Co.

OGN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SD May 29, 2026 FORM SD
144 May 8, 2026
4/A May 7, 2026 FORM 4/A
4 May 7, 2026 FORM 4
10-Q May 4, 2026 10-Q
SCHEDULE 13G Apr 30, 2026
DEFA14A Apr 30, 2026 DEFA14A
DEFA14A Apr 30, 2026 DEFA14A
8-K Apr 30, 2026 FORM 8-K
SCHEDULE 13G Apr 29, 2026
DEFA14A Apr 27, 2026 DEFA14A
DEFA14A Apr 27, 2026 DEFA14A
DEFA14A Apr 27, 2026 DEFA14A
DEFA14A Apr 27, 2026 DEFA14A
8-K Apr 27, 2026 8-K
ARS Apr 24, 2026 ARS
DEFA14A Apr 24, 2026 DEFA14A
DEF 14A Apr 24, 2026 DEF 14A
4 Apr 2, 2026 FORM 4
4 Apr 2, 2026 FORM 4
4 Apr 2, 2026 FORM 4
4 Apr 2, 2026 FORM 4
4 Apr 2, 2026 FORM 4
4 Apr 2, 2026 FORM 4
4 Apr 2, 2026 FORM 4
← Newer Page 2 of 19 · 461 filings Older →